NEURO RELATED ARTICLES
Miscellaneous
Are Scents of Nature
an Untapped Well-Being Boost?
https://neurosciencenews.com/olfaction-nature-wellbeing-26133/
Practice Makes
Perfect: Crystallized Memory Formation Explored
https://neurosciencenews.com/crystallized-memory-practice-26135/
Climate Change
Threatens Brain Health
https://neurosciencenews.com/brain-health-climate-change-26130/
Exercise Can Slow
Brain Aging Cognitive Decline
https://neurosciencenews.com/exercise-aging-cognition-26110/
Covid-19
COVID-19 May Damage
Vision
https://neurosciencenews.com/covid-eye-damage-vision-26105/
Pre-Pandemic Brain Wiring Predicted Teen Mental Health
During COVID
https://neurosciencenews.com/salinece-network-covid-resilience-26138/
Dopamine Disruption
Linked to Autism
https://neurosciencenews.com/dopamine-autism-26109/
Autism and PTSD Are
Vulnerably Linked
https://neurosciencenews.com/asd-ptsd-neuroscience-26067/
Key Brain Region
Implicated in Autism Sensory Issues
https://neurosciencenews.com/acc-hypersensitivity-asd-26073/
Fever
Effect May Improve Autism Symptoms
https://neurosciencenews.com/fever-autism-behavior-26102/
Gut Microbes Influence
Autism-Related Behaviors
https://neurosciencenews.com/microbiome-asd-behavior-26082/
Parasomnia: What
Happens in the Brain During Sleepwalking?
https://neurosciencenews.com/parasomnia-brain-activity-26090/
Exercise Warps Time
Perception
https://neurosciencenews.com/exercise-time-perception-26093/
Knowledge
Do We Really Learn
From Failure?
https://neurosciencenews.com/failure-learning-psychology-26084/
Lack of Sleep in
Childhood Linked to Increased Psychosis Risk
https://neurosciencenews.com/psychosis-child-sleep-26069/
Dreams Dull the
Distress of Emotional Memories Mom’s Stress Hormone Shapes Child’s IQ
https://neurosciencenews.com/dreaming-emotional-memory-26099/
Sleep Apnea During
REM Linked to Memory Decline
https://neurosciencenews.com/rem-sleep-apnea-memory-26109/
Scientific Different
of Male Female
AI Uncovers Hidden
Differences in Male and Female Brain Structures
https://neurosciencenews.com/ai-brain-sex-differences-26101/
Unlocking Sleep’s Role in Emotional Health
https://neurosciencenews.com/sleep-emotional-health-26046/
Sex-Specific
Brain Responses to Alcohol Craving
https://neurosciencenews.com/alcohol-brain-sex-differences-26043/
Virtual Reality
Shows Promise in Treating Depression
https://neurosciencenews.com/depression-virtual-reality-26044/
https://neurosciencenews.com/human-brain-stimulation-neurotech25912/
Training
Enhances Word Recognition for Efficient Reading
https://neurosciencenews.com/word-recognition-reading-learning-25947/
How
Drugs Hijack the Brain’s Reward System
https://neurosciencenews.com/reward-system-drugs-mtorc1-25948/
Brain
Cells That Enhance Memory Focus and Storage Identified
https://neurosciencenews.com/pac-neurons-memory-25938/
Autism’s
Brain Structure Secrets Revealed
https://neurosciencenews.com/autism-brain-structure-25943/
How
We Optimize Decisions for Mutual Benefit
https://neurosciencenews.com/mutual-benefit-decisions-neuroscience-25932/
Monoclonal
Antibody Slows Rapid Motor Decline in Parkinson’s
https://neurosciencenews.com/monoclonal-antibody-parkinsons-25931/
HIV
Drugs May Reduce Alzheimer’s Risk
https://neurosciencenews.com/alzheimers-hiv-drug-25936/
The
Mysteries of Dreams and Their Impact on Our Lives
https://neurosciencenews.com/dreaming-sleep-impact-25928/
How
Sex and Gender Shape Our Cognition
Hippocampus
Generates Deep Sleep Waves
https://neurosciencenews.com/hippocampus-sleep-waves-memory-25897/
Gene
Mutation Increases Autism Risk
https://neurosciencenews.com/autism-genetics-kmt2c-25889/
Insomnia Begins in Childhood
and Persists Through Life
https://neurosciencenews.com/insomnia-neurodevelopment-25882/
Cannabis in Pregnancy Linked
to Autism and ADHD Risk
Inflammation Biomarkers in
Blood of Long-COVID Patients
https://neurosciencenews.com/inflammation-blood-long-covid-25880/
Early Career Work Schedules
Tied to Midlife Health Risks
https://neurosciencenews.com/work-hours-aging-health-25872/
How the Brain Regulates
Emotion
https://neurosciencenews.com/emotion-regulation-mapping-25870/
Genetics of Alcohol Use
Explored
https://neurosciencenews.com/genetics-aud-25866/
Loneliness, Food Cravings, and
the Brain
https://neurosciencenews.com/loneliness-food-cravings-25859/
Environmental Toxins Shorten
Happy Lifespans
https://neurosciencenews.com/happiness-toxins-psychology-25845/
Aging Health: Blended
Antioxidants Boost Memory and Cognition
https://neurosciencenews.com/aging-antioxidants-cognition-25846/
Compound May Curb Alcohol
Dependence
https://neurosciencenews.com/aud-compound-neuropharmacology-25840/
Keto Diet May Improve Mental
Health Symptoms
https://neurosciencenews.com/keto-diet-mental-health-25843/
Babies Predict Actions Based
on Language Community
https://neurosciencenews.com/language-baby-action-25836/
Emotion vs. Reason: Rethinking Decision-Making
https://neurosciencenews.com/emotion-reason-decision-making-25803/
When Do Babies Begin to Be
Conscious?
https://neurosciencenews.com/consciousness-neurodevelopment-25799/
Devil in the Details: The
Visual World of Prosopometamorphopsia
https://neurosciencenews.com/prosopometamorphopsia-visual-neuroscience-25796/
Astrocytes Remember: A New
Layer of Immune Memory Uncovered
https://neurosciencenews.com/astrocytes-immune-memory-25788/
Middle Age is A Critical
Window for Predicting Brain Health
https://neurosciencenews.com/middle-age-brain-health-25778/
Happiness
Takes Practice
https://neurosciencenews.com/happiness-practice-25736/
Brain
Abnormalities in Children with Developmental Language Disorder
https://neurosciencenews.com/brain-abnormalities-idevelopmental-language-disorder-25764/
Brain
Circuit Balances Speech and Breath
https://neurosciencenews.com/speech-breathing-brain-25721/
How
Brain Networks Sustain Attention
https://neurosciencenews.com/attention-network-brain-25915/
Autism
Genes Link to Sound Sensitivity
https://neurosciencenews.com/autism-genetics-sound-sensitivity-25682/
Autism
Social Difficulties Linked to Specific Gene
https://neurosciencenews.com/autism-social-genetics-25685/
Language Processing Problems: A Prelude to Alzheimer’s
https://neurosciencenews.com/language-processing-alzheimers-25683/
Decoding Emotions: Beyond Senses in the Human Brain
https://neurosciencenews.com/sensory-input-emotion-25728/
Bilingualism: Native Language Eases Brain’s Effort
https://neurosciencenews.com/bilingual-native-language-brain-25731/
AI Maps Brain Tissues to Disease Symptoms
https://neurosciencenews.com/language-ai-brain-disease-25756/
Touch and See: Unlocking Early Self-Recognition in
Toddlers
https://neurosciencenews.com/toddler-self-recognition-25755/
Gene Mutation Increases Autism Risk
Summary: Researchers made significant strides in
understanding autism spectrum disorder’s genetic underpinnings. By studying
mice with a frameshift mutation in the KMT2C gene, they observed behavioral and
cognitive impairments resembling ASD symptoms.
Through extensive molecular analyses,
they discovered an unexpected increase in the expression of genes linked to ASD
risk due to KMT2C haploinsufficiency, implicating indirect effects on gene
expression. Remarkably, treatment with the drug vafidemstat showed promise in
correcting these abnormalities, suggesting a potential therapeutic approach for
ASD and similar conditions.
Key Facts:
1.
Researchers found that a frameshift mutation in the KMT2C gene,
leading to haploinsufficiency, models ASD-like symptoms in mice, including
reduced sociality and cognitive impairments.
2.
Contrary to expectations, KMT2C haploinsufficiency resulted in
increased expression of ASD-associated genes, indicating an indirect mechanism
of transcriptomic dysregulation.
3.
Vafidemstat treatment ameliorated social deficits and normalized
gene expression in mutant mice, pointing to a promising therapeutic pathway for
ASD.
Source: Juntendo University
Autism spectrum disorder (ASD)
encompasses neurodevelopmental conditions where patients display repetitive
behavior and impaired sociality. Genetic factors have been shown to influence
the development of ASD.
Additionally, recent studies have shown
that the genes involved in chromatin modification and gene transcription are
involved in the pathogenesis of ASD.
Among the many genes implicated in this
process, the gene KMT2C (lysine methyltransferase 2c),
which codes for a catalytic unit of H3K4 (histone H3 lysine 4)
methyltransferase complex, has been identified to be associated with the
development of autism and other neurodevelopmental disorders.
They observed that the altered
genes associated with ASD risk were predominant in undifferentiated radial
glial cells. Credit: Neuroscience News
Previous studies have shown that
haploinsufficiency (a condition where, of the two copies of the gene, only one
remains functional) of KMT2C is a risk factor for ASD and
other neurodevelopmental disorders. However, the molecular mechanism through
which the loss-of-function mutation in KMT2C leads to these
conditions remains unclear.
To address this knowledge gap,
researchers from Juntendo University, RIKEN, and the University of Tokyo in
Japan aimed to provide answers to these questions in a
benchmark study published in the journal Molecular Psychiatry on
26 March 2024. The research team included Professor Tadafumi Kato from the
Department of Psychiatry and Behavioral Science at Juntendo University Graduate
School of Medicine, Dr. Takumi Nakamura and Dr. Atsushi Takata from the RIKEN
Center for Brain Science, and Professor Takashi Tsuboi from Graduate School of
Arts and Sciences, The University of Tokyo.
To get to the bottom of KMT2C’s
role in ASD pathogenesis, the team developed and analyzed genetically
engineered strain mice (Kmt2c+/fs) having a frameshift
mutation that models the KMT2C haploinsufficiency.
They then performed various behavioral
analyses, in which they observed that the mutant mice exhibited lower
sociality, inflexibility, auditory hypersensitivity, and cognitive impairments,
which are all ASD-related symptoms.
Next, they performed transcriptomic and
epigenetic profiling to understand the basis of the molecular changes observed
in the mutant mice. What they discovered was remarkable: the genes associated
with increased ASD risk showed higher expression in these mutant mice.
Dr. Takata exclaims, “This was
somewhat unexpected. KMT2C mediates H3K4 methylation, which is thought to
activate gene expression, and thereby KMT2C haploinsufficiency was expected to
cause reduced expression of target genes.”
To gain mechanistic insights into their
finding, the researchers carried out chromatin immunoprecipitation, a technique
to determine the location on the DNA where the protein interacts with it.
They found an overlap between KMT2C and
the differentially expressed genes exhibiting reduced expression, suggesting
that KMT2C haploinsufficiency leads to ASD-related
transcriptomic changes through an indirect effect on gene expression.
Further, to identify the cell types that
contribute more to the pathological changes seen in the mutant mice, the
researchers performed single-cell RNA sequencing of newborn mice brains. They
observed that the altered genes associated with ASD risk were predominant in
undifferentiated radial glial cells.
However, a gross change in the cell
composition was not observed, implying that the transcriptomic dysregulation
does not severely impact cell fate.
Finally, the researchers tested the
effects of vafidemstat, a brain penetrant inhibitor of LSD1 (lysine-specific
histone demethylase 1A), that could ameliorate histone methylation
abnormalities.
They found that vafidemstat improved the
social deficits in the mutant mice and had an exceptional rescuing effect by
changing the expression levels of the differentially expressed genes to their
normal expression level. This finding showed that vafidemstat is a valid drug
for mutant mice and can potentially help restore the normal transcriptomic
state.
What sets this discovery apart is that
it challenges the commonly held belief that ASD disability may not be cured and
demonstrates the efficacy of vafidemstat in improving ASD-like phenotypes.
The results open doors to future
research to strengthen the foundation for the pharmacologic treatment of ASD
and other neurodevelopmental disorders. Prof. Kato concludes, “Our
research shows that drugs similar to vafidemstat may be generalizable to
multiple categories of psychiatric disorders.”
About this genetics and autism research news
Author: Yoshitaka Nakashima
Source: Juntendo University
Contact: Yoshitaka Nakashima – Juntendo University
Image: The image is credited to Neuroscience News
Original
Research: Open
access.
“Transcriptomic dysregulation and
autistic-like behaviors in Kmt2c haploinsufficient
mice rescued by an LSD1 inhibitor” by Tadafumi Kato et al. Molecular Psychiatry
Abstract
Transcriptomic dysregulation and
autistic-like behaviors in Kmt2c haploinsufficient mice rescued by an LSD1 inhibitor
Recent studies have consistently
demonstrated that the regulation of chromatin and gene transcription plays a
pivotal role in the pathogenesis of neurodevelopmental disorders.
Among many genes involved in these
pathways, KMT2C, encoding one of the six known histone H3 lysine
4 (H3K4) methyltransferases in humans and rodents, was identified as a gene
whose heterozygous loss-of-function variants are causally associated with
autism spectrum disorder (ASD) and the Kleefstra syndrome phenotypic spectrum.
However, little is known about how KMT2C haploinsufficiency
causes neurodevelopmental deficits and how these conditions can be treated.
To address this, we developed and
analyzed genetically engineered mice with a heterozygous frameshift mutation
of Kmt2c (Kmt2c+/fs mice) as a
disease model with high etiological validity. In a series of behavioral
analyses, the mutant mice exhibit autistic-like behaviors such as impairments
in sociality, flexibility, and working memory, demonstrating their face
validity as an ASD model.
To investigate the molecular basis of
the observed abnormalities, we performed a transcriptomic analysis of their
bulk adult brains and found that ASD risk genes were specifically enriched in
the upregulated differentially expressed genes (DEGs), whereas KMT2C peaks
detected by ChIP-seq were significantly co-localized with the downregulated
genes, suggesting an important role of putative indirect effects of Kmt2c haploinsufficiency.
We further performed single-cell RNA
sequencing of newborn mouse brains to obtain cell type-resolved insights at an
earlier stage.
By integrating findings from ASD exome
sequencing, genome-wide association, and postmortem brain studies to
characterize DEGs in each cell cluster, we found strong ASD-associated
transcriptomic changes in radial glia and immature neurons with no obvious bias
toward upregulated or downregulated DEGs. On the other hand, there was no
significant gross change in the cellular composition.
Lastly, we explored potential
therapeutic agents and demonstrate that vafidemstat, a lysine-specific histone
demethylase 1 (LSD1) inhibitor that was effective in other models of
neuropsychiatric/neurodevelopmental disorders, ameliorates impairments in
sociality but not working memory in adult Kmt2c+/fs mice.
Intriguingly, the administration of
vafidemstat was shown to alter the vast majority of DEGs in the direction to
normalize the transcriptomic abnormalities in the mutant mice (94.3 and 82.5%
of the significant upregulated and downregulated DEGs, respectively, P < 2.2 × 10−16,
binomial test), which could be the molecular mechanism underlying the
behavioral rescuing.
In summary, our study expands the
repertoire of ASD models with high etiological and face validity, elucidates
the cell-type resolved molecular alterations due to Kmt2c haploinsufficiency,
and demonstrates the efficacy of an LSD1 inhibitor that might be generalizable
to multiple categories of psychiatric disorders along with a better
understanding of its presumed mechanisms of action.
Comments
Post a Comment